Efficacy of troglitazone measured by insulin resistance index

The results of a double-blind study of troglitazone thearpy revealed that the agent improves glycemic indices in Japanese and white patients with non-insulin dependent diabetes mellitus.

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 1997-07, Vol.350 (9072), p.184-184
Main Authors: Nagasaka, Shoichiro, Iwamoto, Yasuhiko, Ishikawa, San-e, Kuzuya, Takeshi, Saito, Toshikazu
Format: Article
Language:English
Subjects:
Biological and medical sciences
Chromans - therapeutic use
Clinical trials
Diabetes
Diabetes Mellitus, Type 2 - drug therapy
Drug therapy
Female
Hormones. Endocrine system
Humans
Hypoglycemic Agents - therapeutic use
Insulin Resistance
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Thiazoles - therapeutic use
Thiazolidinediones
Treatment Outcome
Troglitazone
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The results of a double-blind study of troglitazone thearpy revealed that the agent improves glycemic indices in Japanese and white patients with non-insulin dependent diabetes mellitus.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(05)62350-1